µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º [
|;Zxb:
uA/.4 b
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ C=_-p"O#
$8T|r+<
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) Gv+Tg/
0*:hm%g
1. ICAM-1 ESf7b `tS
GqD!W8+
2. interleukin 12(IL-12) .gkPG'm[
=5=Vm[
3. tumor infiltrating lymphocyte -S3+
h$Y8
tDLk ZCP
4. TCR/CD3 complex 2=,Sz1`t
#m$% S%s
5. hematopoietin receptor family tD0>(41K
w{O3P"N2
6. individual idiotype(IdI) I~]mX;
_NqT8C4C
7. integrin N[bf.5T
t-x"(
8. colony-stimulatory factor (CSF) &?Z)V-1H
pD6g+Taj
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© +e4<z%1
dQ|Ht[s=
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? l}-`E@w
ee0>B86tE
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ R}6la.mQ
YB1DL^:
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷ÓᣠvG_v89t!ex
2:/MN2
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ xA'#JN<*
jLS]^|
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) o4'4H y
@wgGnb)
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ c%/&@vs7
d?y\~<
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) %c/"A8{ eb
G
/3lX^Z>
3. immunoglobulin superfamily (IgSF) ];~[Olc
Y9y*":&%
4. selectin i{[H
3p8
|A/_Qe|s2
5. anti-idiotypic antibody (¦ÁId) 35kbE'
]%8;c
6. major histocompatibility complex(MHC) R{A/+7!
f /i,Zw
7. immunotolerance 6U9Fa=%>}
N_[ Q.HD"
8. biological reponse modifier(BRM) ~EkGG
.
[\n.[4gq"
9. immune reponse gene (Ir gene) %_O>Hy|p
6-}e-H
10. reshaped antibody (or reconstituted antibody) 'wV26Dm
@@mW+16
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© T\CQ
> 0)`uJ
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ v$/i5kcWx
@$}\S
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? &n kGdHX/a
<!XnUCtV
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ }U1shG[
([o:_5/8I
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? R!xc$`N
Ap18qp
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ UpBYL?+L
>&Lu0oHH
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? j'cCX[i
7O :Gi*MA
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ Ll48)P{+}V
OZ9j3Q;a$
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ 0k]N%!U
:b)@h|4
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? rVmO/Y#Hx$
P^+>QJ1
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ @cNI|T
ueo3i1
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: )A;<'{t #L
1h{_v!X
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: NKYyMHv6
:7*\|2z
A
̉񧄤 ^r$5];n
|9M
y>8k(
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© vUA`V\
Zwl?*t\D
1. CD8 FiL
JF!
<
3OV
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) EB,>k1IJ
'KG`{K
$
3. immunoglobulin fold(Ig fold) 7
G2N&v>
'(*D3ysU
4. cadherin (Ca-dependent cell adhesion moleculers) YSmz)YfX9
d~%Rnic6*
5. idiotype-anti-idiotypic antibody immune network theory TA5M4r6
UI'eD)WR
6. HLA class II antigen " OtLJ
f}4h}Cq
7. complementarity-determining region (CDR) -B!pg7>'##
l.!
~t1i
8. perforin(or pore-forming protein ,PFP) %yVZ|
d*Q
7)#/I
9. high affinity IL-2 receptor Zup?nP2GkT
!JA63
10. artificial active immunization DJ
.Ct4
*lSIT]1
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© 2UquN0
V{r@D!}
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦Óᣠ%;S5_K,
}sZ]SE
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 ;I0/zeM%
:H{8j}"
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ $- L)
>"
[+GG Wo
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ g;pymz
y[vjqfdmU
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ JkmL'Zk>:
f]4gDmn^
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? Vz^:|qON
lF<(yF5
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ &uM?DQ`o8
$f%_ 4 =
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ bCsQWsj^NW
O_033&
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ bm^ou#]|
>9DgsA`'
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ l\eq/yg_
lL?;?V~
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© _LK(j;6K}
G100L}d"N
1. immunoglobulin gene rearrangement CA3.fu3(p
rpd3Rp
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) /{lls2ycW%
NXV%j},>
3. flow cytometry(FCM) 6^~&sA
Z^sO`C
4. carrier effect IL<5Suz:
kn!J`"b
5. positive selection of T lymphocytes in thymus PW}Yts7p
#2pgh?
6. mouse TH1(Th1) and TH2(Th2) subsets &B)
F_E I
-Iq#h)Q*
7. perforin (pore-forming protein ,PFP) Ys\l[$_`*
/HLQ
8. ADCC(antibody-dependent cell-mediated cytotoxicity) re<"%D
1$c*/Tc:E
9. SH-2(src-homology region 2) N@k:kI
o;"!#Z 1SJ
10. Ab2¦Â (internal image) 5ewQjwW0
$XJe)
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© R^D~ic
N
Blu^\:?#z-
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? ==$Ox6.
[}FP_Su$6
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? B64%|
S
aFhsRE?YC=
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦ÓᣠZ#9{1sHEP
#u#s'W
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£ F7mzBrz
?L|@{RS{|
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠH>M0GL
$)kIYM&
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) 4H{L>e
T1D7H~\lG
ÃâÒßѧרҵ£º t0?\5q
W(EU*~<UC
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ R D)dw
%2V_%KA
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? nc([e9_9v
16xM?P
´«È¾²¡Ñ§×¨Òµ£º ,)%nLc
c_%vD~6W-
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ he
9qWL&^G
ZcIwyh(`
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ OfIml.
i |cSO2O+
Ïû»¯×¨Òµ£º <.~j:GbsE
z9E*Mh(NE
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ r*y4Vx7
!i0:1{.
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? I9TOBn|6
=f?| f
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ lfb]xu]O
8q}`4wCD$
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© & Z*&&
enE8T3
1. Fas(CD95)/FasL 6imDA]5N&
NgQ {'H[Y
2. common chain of cytokine receptor t d-EB&i\
[iB`- dE,
3 . TCR/CD3 complex x~Y]c"'D
tBp dKJn##
4. negaive selection of thymocytes 5 o'V}
cea%M3
5. artificial active immune NDm3kMa
fMP$o3;
6. anti-idiotypic ldO6W7G|h
P]bI".A8
7. IgSF xOp8[6Ga'
o&-q.;MY
8. Integrin v=RQ"iv8
VMe~aUd
9. chemokine E}00y%@*J
8%@7G*
10. B7/CD28 S8TJnv`?'
Z4b<$t[u
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© ckHHD|
KD11<&4_x
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ }YfM<
nB[Aw7^|A
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ j|N;&s`
gf$5pp-
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ sL[&y'+
*F42GiBZR
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£ 8vjaQ5
fo;Ftf0
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ ]2`PS<a2
{9S=:
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ 'Y Bz?l9
Yw&{.<sL
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© kC"lO'
kmXpj3
1. B7/CD28 )u ) ]#z
PQ9.aJdw@-
2. Th1 subset +KGZk?%
zkHwoAD;t8
3. seven predicated transmembrane domain receptor superfamily£¨STR superfamily£© J{<,V\t)
>G(M&
4. antibody affinity maturation w7GF,a
_1TSt%L
5. AP-1 4Y2l]86
-b'93_ZTu:
6. single chain variable fragment£¨ScFv£© cyu)YxT
R-CFF
7. NK cell receptor }A)>sQ
o_C
j o
8. Zinkernagel-Doherty phenomenon aMI\gCB/
.b'hVOs{
9. Ig fold I`"B<=zi
^wDZg`
10. CD40/CD40L lrQ +G@#
rBG8.E36J
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²36·Ö£© N]qX^RSb
=73""ry
1. ÊÔÊöÐØÏÙ΢»·¾³¶ÔÐØÏÙϸ°ûµÄÑ¡Ôñ×÷Óü°ÆäÓëTϸ°û¹¦ÄÜÐÔÑÇȺÐγɵĹØÏµ¡£ 57W4E{A
9;,_Qq
2. ÊÔÊöÌåÒºÃâÒßÓ¦´ðµÄ¹æÂÉ£¬»ØÒä·´Ó¦ºÍ¿¹ÌåÀà±ðת»»µÄ»úÖÆÊÇʲô£¿ g_{hB5N](7
TXx%\V_6
3. ÊԴӽṹºÍ¹¦ÄܵȽǶȣ¬²ûÊö°×ϸ°û·Ö»¯¿¹Ô£¨CD£©¡¢Õ³¸½·Ö×Ó£¨integrin£©ºÍÃâÒßÇòµ°°×³¬¼Ò×壨IgSF£©ÈýÀà·Ö×ÓµÄÏ໥¹ØÏµ¡£Ä¿Ç°ÔÚÕâÒ»ÁìÓòÖÐÖ÷ÒªÑо¿ÈȵãÊÇʲô£¿ &d/v/Y
"7Qc:<ww
Èý. ÎÊ´ðÌ⣨24·Ö£¬µÚ1ÌâΪÃâÒßѧרҵ¿¼ÉúÊÔÌ⣬µÚ2ÌâΪѪҺ²¡Ñ§¿Æ¿¼ÉúÊÔÌ⣬µÚ3ÌâΪÏû»¯ÄÚ¿Æ¿¼ÉúÊÔÌ⣬ֻÔÊÐí´ð±¾×¨ÒµÊÔÌ⣩ 'Y`.0T[&
@k.j6LKbc
1. ÊԱȽÏTCRºÍBCR½á¹¹¼°Æäʶ±ð¿¹Ô¡¢ÁܰÍϸ°û»î»¯ÐźŵķÖ×Ó»úÀí¡££¨ÃâÒßѧרҵ£©¡£ qgTN %%"~
k8]=5C?k
2. ÊÔÊö°×Ѫ²¡ÃâÒßѧ·ÖÐÍÀíÂۺͷ½·¨µÄÑо¿½øÕ¹¡££¨ÑªÒº²¡Ñ§×¨Òµ£©¡£ CYlZ<